StreetInsider.com News Articles

Form 424B2 Pyxis Oncology, Inc.

Fri, 28 Aug 2026 07:06:00 -0400

si-local-file:///var/storage/secattach/20260828/26992973.html

Form 424B2 Pyxis Oncology, Inc.

Fri, 28 Aug 2026 07:06:00 -0400

si-local-file:///var/storage/secattach/20260828/26992973.html

Form EFFECT Pyxis Oncology, Inc.

Fri, 28 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260828/26992642.html

Form EFFECT Pyxis Oncology, Inc.

Fri, 28 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260828/26992642.html

Form 4 Pyxis Oncology, Inc. For: Aug 20 Filed by: Dupont Jakob

Thu, 20 Aug 2026 18:19:00 -0400

si-local-file:///var/storage/secattach/20260820/26957374.html

Form 4 Pyxis Oncology, Inc. For: Aug 20 Filed by: Dupont Jakob

Thu, 20 Aug 2026 18:19:00 -0400

si-local-file:///var/storage/secattach/20260820/26957374.html

Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders

Thu, 20 Aug 2026 16:31:07 -0400

Pyxis Oncology (NASDAQ: PYXS) filed for up to 39,200,306 share offering by selling stockholders.

Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders

Thu, 20 Aug 2026 16:31:07 -0400

Pyxis Oncology (NASDAQ: PYXS) filed for up to 39,200,306 share offering by selling stockholders.

Form S-3 Pyxis Oncology, Inc.

Thu, 20 Aug 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260820/26956523.html

Form S-3 Pyxis Oncology, Inc.

Thu, 20 Aug 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260820/26956523.html

Form 4 Pyxis Oncology, Inc. For: Aug 12 Filed by: Civik Thomas

Fri, 14 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260814/26930359.html

Form 4 Pyxis Oncology, Inc. For: Aug 12 Filed by: Civik Thomas

Fri, 14 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260814/26930359.html

Form 10-Q Pyxis Oncology, Inc. For: Jun 30

Thu, 13 Aug 2026 07:45:00 -0400

si-local-file:///var/storage/secattach/20260813/26916594.html

Form 10-Q Pyxis Oncology, Inc. For: Jun 30

Thu, 13 Aug 2026 07:45:00 -0400

si-local-file:///var/storage/secattach/20260813/26916594.html

Form 8-K Pyxis Oncology, Inc. For: Aug 13

Thu, 13 Aug 2026 07:43:00 -0400

si-local-file:///var/storage/secattach/20260813/26916571.html

Form 8-K Pyxis Oncology, Inc. For: Aug 13

Thu, 13 Aug 2026 07:43:00 -0400

si-local-file:///var/storage/secattach/20260813/26916571.html

Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c

Thu, 13 Aug 2026 07:23:34 -0400

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q2 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Thu, 13 Aug 2026 07:00:00 -0400

Updated data from the MICVO Phase 1 monotherapy study in 2L+ R/M HNSCC on track to be reported in Fall 2026; update to include detailed analyses of patients treated at or below a dose cap

Updated data from the MICVO Phase 1/2 combination study with pembrolizumab in 1L R/M HNSCC on track to be reported in the fourth quarter of 2026

Completed private placement financing for up to $114 million, providing approximately $50 million in upfront gross proceeds to support additional patient follow-up

Upfront proceeds from

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Thu, 13 Aug 2026 07:00:00 -0400

Updated data from the MICVO Phase 1 monotherapy study in 2L+ R/M HNSCC on track to be reported in Fall 2026; update to include detailed analyses of patients treated at or below a dose cap

Updated data from the MICVO Phase 1/2 combination study with pembrolizumab in 1L R/M HNSCC on track to be reported in the fourth quarter of 2026

Completed private placement financing for up to $114 million, providing approximately $50 million in upfront gross proceeds to support additional patient follow-up

Upfront proceeds from

Wells Fargo Starts Pyxis Oncology Inc. (PYXS) at Overweight

Mon, 03 Aug 2026 09:01:05 -0400
(Updated - August 3, 2026 9:01 AM EDT)
Wells Fargo analyst Derek Archila initiates coverage on Pyxis Oncology Inc. (NASDAQ: PYXS) with a Overweight rating and a price target of $12.00.
tHE ANALYST COMMENTS "We think the Street underappreciates two things: dose capping likely addresses concerns on MICVO's safety, and the 2L+ HNSCC oppty is wide open as EGFR bispecifics take over 1L. Our base case forecasts shares at least doubling on the Fall '26 update. Efficacy looks differentiated, not incremental. MICVO is a first-in-class ADC targeting EDB+FN in the tumor stroma—independent of EGFR, PD-L1 and HPV status—and its 46% confirmed ORR

Wells Fargo Starts Pyxis Oncology Inc. (PYXS) at Overweight

Mon, 03 Aug 2026 09:01:05 -0400
(Updated - August 3, 2026 9:01 AM EDT)
Wells Fargo analyst Derek Archila initiates coverage on Pyxis Oncology Inc. (NASDAQ: PYXS) with a Overweight rating and a price target of $12.00.
tHE ANALYST COMMENTS "We think the Street underappreciates two things: dose capping likely addresses concerns on MICVO's safety, and the 2L+ HNSCC oppty is wide open as EGFR bispecifics take over 1L. Our base case forecasts shares at least doubling on the Fall '26 update. Efficacy looks differentiated, not incremental. MICVO is a first-in-class ADC targeting EDB+FN in the tumor stroma—independent of EGFR, PD-L1 and HPV status—and its 46% confirmed ORR

Form 3 Pyxis Oncology, Inc. For: Jun 30 Filed by: Gordon Craig D

Fri, 10 Jul 2026 16:10:00 -0400
si-local-file:///var/storage/secattach/20260710/26757435.html

Form 3 Pyxis Oncology, Inc. For: Jun 30 Filed by: Gordon Craig D

Fri, 10 Jul 2026 16:10:00 -0400
si-local-file:///var/storage/secattach/20260710/26757435.html

Form SCHEDULE 13G Pyxis Oncology, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Fri, 10 Jul 2026 16:08:00 -0400
si-local-file:///var/storage/secattach/20260710/26757410.html

Form SCHEDULE 13G Pyxis Oncology, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Fri, 10 Jul 2026 16:08:00 -0400
si-local-file:///var/storage/secattach/20260710/26757410.html